acut
viral
infect
induc
stress
within
infect
cell
integr
stress
respons
isr
activ
mani
cell
viral
infect
isr
facilit
cellular
surviv
return
homeostasi
initi
cell
death
signal
condit
sever
stress
initi
stressor
maintain
four
distinct
stress
kinas
activ
respons
stress
although
kinas
may
number
substrat
phosphoryl
alpha
subunit
eukaryot
translat
initi
factor
serin
posit
phosphoryl
gtpexchang
factor
unabl
exchang
gdp
gtp
consequ
becom
sequest
effect
level
drop
prevent
effici
format
ternari
complex
thu
inhibit
translat
initi
four
cellular
kinas
known
phosphoryl
hemeregul
kinas
hri
gener
control
nondepress
doublestrand
rnadepend
protein
kinas
pkr
pkrlike
er
kinas
perk
cell
intrins
extrins
stress
activ
kinas
oxid
stress
ii
acid
starvat
iii
doublestrand
rna
occur
viral
infect
iv
unfold
protein
endoplasm
reticulum
er
howev
redund
exist
amongst
kinas
exampl
activ
respons
er
stress
cell
lack
perk
four
kinas
activ
oxid
stress
follow
kinas
phosphoryl
translat
initi
reduc
de
novo
protein
synthesi
inhibit
respons
stress
granul
sg
form
cytoplasm
sg
assembl
mediat
rna
bind
protein
tcell
antigen
relat
protein
tiar
rasgap
protein
result
compartment
translationallystal
mrna
transcript
rnabind
protein
ribosom
translat
initi
factor
sg
consid
site
mrna
triag
protect
mrna
transcript
stress
allevi
cell
return
homeostasi
mani
virus
prevent
activ
isr
maintain
protein
translat
ensur
success
viral
infect
virus
target
initi
kinas
andor
downstream
effector
mechan
isr
cell
initi
kinas
pkr
inhibit
knock
often
permiss
viral
replic
howev
virus
benefit
inhibit
kinas
activ
initi
isr
studi
examin
role
pathway
mammalian
orthoreoviru
reoviru
infect
found
strain
reduc
titer
pkr
knockout
murin
embryon
fibroblast
mef
followup
studi
observ
increas
isr
gene
express
reduc
level
kinas
inhibitor
cell
infect
reoviru
strain
known
robustli
interfer
host
translat
strain
replic
less
effici
mef
express
nonphosphorylat
form
reoviru
infect
also
modul
sg
format
occur
downstream
isr
activ
earli
infect
enter
viral
core
particl
local
sg
form
within
infect
cell
howev
within
h
infect
sg
disappear
viral
factori
vf
site
reoviru
replic
translat
assembl
becom
promin
reovirusinfect
cell
sg
protein
gtpaseactiv
protein
domain
bind
protein
local
margin
vf
mediat
interact
nonstructur
viral
protein
also
interact
nonstructur
protein
form
matrix
vf
coexpress
suffici
alter
local
suppress
sg
induct
interplay
phosphoryl
pkr
activ
translat
shutoff
sg
format
straindepend
sg
format
neg
impact
replic
strain
reoviru
togeth
studi
suggest
uniqu
role
isr
reoviru
infect
given
previou
observ
reoviru
replic
lower
titer
cell
impair
isr
hypothes
reoviru
infect
would
enhanc
cell
isr
activ
prior
infect
test
util
chemic
sodium
arsenit
sa
appli
cell
sa
lead
product
reactiv
oxygen
speci
ro
oxid
stress
respons
increas
ro
level
hri
kinas
phosphoryl
induc
sg
format
ultim
lead
translat
inhibit
found
activ
isr
pretreat
cell
sa
prior
viru
adsorpt
reoviru
infect
effici
increas
permiss
protein
express
replic
sainduc
enhanc
reoviru
infect
observ
reoviru
strain
test
depend
celltyp
time
sa
addit
enhanc
viral
infect
observ
sa
ad
cell
within
h
inocul
maxim
enhanc
addit
occur
prior
inocul
suggest
relationship
isr
earli
replic
event
furthermor
activ
isr
equal
benefici
heat
shock
hs
prior
infect
impact
viral
replic
taken
togeth
data
suggest
critic
role
isr
reoviru
infect
activ
isr
sa
prior
reoviru
infect
benefici
cell
type
studi
expand
upon
previou
observ
reoviru
replic
reduc
titer
cell
lack
phosphorylat
help
clarifi
uncertainti
field
time
sg
induct
reoviru
reoviru
oncolyt
viru
preferenti
infect
lyse
cancer
cell
insight
reoviru
infect
activ
stress
respons
respons
modul
enhanc
infect
could
help
maxim
oncolyt
potenti
viru
atcc
va
usa
hela
cell
atcc
maintain
eagl
minimum
essenti
medium
mem
cellgro
corn
ny
usa
contain
fetal
bovin
serum
fb
hyclon
ge
life
scienc
usa
mm
sodium
pyruv
cellgro
mm
lglutamin
cellgro
presenc
cell
maintain
mem
contain
fb
mm
lglutamin
presenc
human
pancreat
ductal
epitheli
hpde
cell
kerafast
usa
maintain
keratinocyt
sfm
invitrogen
usa
supplement
mg
bovin
pituitari
extract
human
recombin
epiderm
growth
factor
provid
media
presenc
sa
obtain
sigmaaldrich
kindli
donat
dr
shube
qian
cornel
univers
use
final
concentr
mm
experi
reovirus
type
lang
type
dear
laboratori
stock
origin
isol
respect
repres
clonal
isol
ml
nibert
laboratori
harvard
medic
school
prototyp
reoviru
serotyp
strain
abney
kind
gift
dr
barbari
sherri
north
carolina
state
univers
viru
twice
plaquepurifi
pass
two
three
time
cell
monolay
subject
three
cycl
work
cell
lysat
viru
stock
titer
l
cell
immunofluoresc
stain
note
text
use
experi
hela
hpde
cell
seed
cultur
plate
contain
mm
glass
coverslip
cultur
plate
day
give
rise
confluenc
prior
infect
cell
infect
viru
indic
multipl
infect
moi
h
room
temperatur
rt
phosphatebuff
salin
pb
ph
supplement
mm
rock
everi
min
follow
absorpt
viru
remov
cell
incub
growth
medium
harvest
indic
time
point
sg
induc
cell
use
follow
mechan
treatment
mm
sa
normal
growth
media
min
prior
infect
min
prior
harvest
hs
normal
growth
media
preheat
incub
min
prior
infect
harvest
cell
manual
determin
contain
sg
immunofluoresc
reveal
minimum
three
granul
costain
tiar
follow
commerci
primari
antibodi
use
immunoblot
mous
monoclon
antibodi
novu
biolog
co
usa
mous
monoclon
antitiar
antibodi
santa
cruz
biotechnolog
tx
usa
mous
monoclon
santa
cruz
biotechnolog
rabbit
polyclon
genetex
ca
usa
mous
monoclon
antibodi
novu
biolog
mous
monoclon
antihri
santa
cruz
biotechnolog
reoviru
protein
express
assess
use
chicken
polyclon
antiserum
prepar
bacteriallyexpress
purifi
antigen
covanc
mous
monoclon
clone
kind
gift
dr
terenc
dermodi
univers
pittsburgh
secondari
antibodi
use
immunoblot
follow
hrp
donkey
antimous
igg
jackson
immunoresearch
pa
usa
hrp
donkey
antichicken
igi
jackson
immunoresearch
primari
antibodi
use
immunofluoresc
includ
mous
monoclon
bd
bioscienc
ca
usa
rabbit
monoclon
antitiar
cell
signal
technolog
usa
detect
viral
factori
secondari
antibodi
use
immunofluoresc
assay
includ
alexa
fluor
goat
antichicken
igg
alexa
fluor
goat
antirabbit
igg
alexa
fluor
goat
antimous
igg
alexa
fluor
goat
antirabbit
igg
thermofish
ny
usa
cell
wash
pb
supplement
mm
fix
room
temperatur
min
paraformaldehyd
pb
fix
cell
wash
pb
permeabil
triton
pb
min
wash
three
time
pb
cell
block
min
stain
buffer
sb
saponin
mm
glycin
fb
pb
incub
primari
antibodi
dilut
sb
h
cell
wash
one
time
pb
incub
secondari
antibodi
dilut
sb
h
coverslip
mount
onto
glass
slide
prolong
gold
antifad
reagent
dapi
prime
thermofish
imag
obtain
use
olympu
invert
microscop
equip
phase
fluoresc
optic
imag
collect
digit
olympu
color
cmo
camera
cellsen
standard
softwar
olympu
usa
process
prepar
present
use
photoshop
cc
adob
ca
usa
softwar
determin
percent
cell
contain
sg
vf
minimum
three
individu
experi
perform
within
experi
minimum
four
field
view
manual
count
total
less
cell
per
condit
field
select
randomli
scan
exclus
dapi
channel
cell
consid
posit
sg
contain
minimum
three
granul
costain
tiar
cell
consid
infect
contain
inclus
vf
cell
lyse
pb
contain
mm
nacl
mm
trishcl
ph
edtafre
proteas
inhibitor
cocktail
sigma
aldrich
mo
usa
min
ice
clarifi
centrifug
retain
supernat
cell
lysat
resolv
sdspage
protein
detect
use
antibodi
describ
imag
collect
use
cdigit
digit
scanner
imag
studio
digit
softwar
version
licor
ne
usa
appropri
immunoblot
incub
strip
buffer
mm
glycin
mm
sd
tween
ph
reprob
densitometri
analysi
perform
measur
intens
band
use
imag
studio
digit
softwar
rel
densiti
normal
densiti
target
proteinnorm
densiti
load
control
cell
infect
wash
pb
supplement
mm
incub
growth
medium
indic
time
cell
subject
two
freezethaw
cycl
prior
determin
viral
titer
standard
reoviru
plaqu
assay
cell
briefli
serial
dilut
lysat
use
infect
monolay
cell
overlay
agar
contain
tlck
sigma
aldrich
mo
usa
facilit
plaqu
format
follow
incub
day
plaqu
visual
count
determin
viral
titer
plaqueform
unit
pfu
ml
follow
equat
use
pfuml
number
plaqu
v
dilut
factor
v
volum
dilut
viruswel
previou
report
suggest
sg
form
follow
infect
reoviru
report
conflict
sg
appear
disappear
infect
cell
select
perform
analys
african
green
monkey
kidney
cell
commonli
use
line
reoviru
field
first
confirm
sg
could
form
cell
treat
uninfect
cell
mm
sa
min
fix
coimmunostain
tiar
two
rna
bind
protein
requir
sg
format
observ
sg
treat
cell
confirm
cell
form
sg
figur
top
row
figur
next
evalu
capac
reoviru
induc
sg
format
absenc
sa
infect
cell
reoviru
multipl
infect
moi
indic
time
postinfect
pi
fix
coimmunostain
cell
presenc
sg
tiar
vf
figur
lower
panel
figur
sg
absent
mockinfect
cell
began
appear
well
infect
around
h
pi
found
sg
format
reovirusinfect
well
peak
around
h
pi
total
cell
contain
sg
h
pi
percentag
cell
contain
sg
drop
h
pi
percentag
cell
contain
sg
differ
mockinfect
cell
figur
b
figur
previou
report
detect
sg
reovirusinfect
human
prostat
carcinoma
cell
h
post
infect
unabl
detect
sg
reoviru
infect
cell
late
time
post
infect
varieti
moi
figur
bottom
row
figur
middl
row
howev
local
peripheri
vf
infect
cell
h
pi
figur
middl
row
seen
h
pi
figur
top
row
furthermor
treat
infect
cell
sa
h
pi
immedi
harvest
other
done
could
observ
puncta
peripheri
vf
infect
cell
figur
find
agreement
choudhuri
et
al
found
local
vf
peripheri
reoviru
infect
determin
reoviru
alter
express
level
sg
protein
next
evalu
tiar
protein
express
infect
figur
level
remain
rel
constant
cours
infect
note
increas
tiar
express
h
pi
immunoblot
independ
moi
addit
increas
tiar
express
h
evid
mock
reovirusinfect
cell
figur
find
contrast
immunofluoresc
data
present
figur
chang
overal
tiar
express
note
howev
observ
local
tiar
shift
time
tiar
express
primarili
local
nucleu
earli
time
post
infect
primarili
found
cytoplasm
late
time
post
infect
figur
togeth
data
suggest
reoviru
infect
induc
sg
earli
late
time
postinfect
cell
follow
infect
reoviru
viral
protein
orchestr
format
vf
site
viru
replic
assembl
translat
cellular
factor
involv
translat
ribosom
subunit
recruit
vf
mani
initi
factor
similarli
compartment
within
sg
date
studi
focus
induct
sg
respons
viral
infect
viral
suppress
sg
format
infect
knowledg
studi
perform
assess
impact
presenc
sg
initi
reoviru
infect
explor
first
examin
effect
sg
presenc
viral
protein
express
cell
infect
moi
either
pretreat
ad
mm
sa
min
start
infect
pre
posttreat
ad
sa
min
immedi
harvest
post
cell
lysat
collect
h
pi
express
level
nonstructur
viral
protein
determin
first
detect
h
pi
h
pi
express
level
consist
higher
cell
pretreat
sa
compar
untreat
cell
cell
treat
sa
min
harvest
figur
consist
figur
express
level
remain
rel
constant
throughout
cours
infect
respons
variou
treatment
figur
viral
protein
necessari
format
vf
reoviru
infect
next
explor
elev
express
consequ
increas
number
infect
cell
found
cell
pretreat
mm
sa
min
prior
reoviru
infect
cell
infect
contain
vf
h
pi
wherea
untreat
cell
infect
h
pi
observ
similar
pattern
h
pi
figur
c
given
increas
percentag
infect
cell
dish
pretreat
sa
test
pretreat
cell
also
enhanc
viral
yield
found
pretreat
sa
led
modest
signific
increas
viral
titer
pfuml
independ
moi
consist
increas
number
infect
cell
increas
protein
express
figur
assess
function
consequ
sa
pretreat
reoviru
replic
perform
onestep
growth
curv
cell
infect
reoviru
moi
differ
two
group
earli
time
follow
infect
h
viral
titer
consist
higher
cell
pretreat
sa
late
time
post
infect
figur
togeth
data
indic
pretreat
cell
sa
enhanc
reoviru
infect
increas
number
viruspermiss
cell
previou
report
suggest
reovirusinduc
sg
format
celltyp
specif
therefor
next
sought
determin
replic
enhanc
observ
cell
seen
cell
type
select
three
addit
cell
type
repres
varieti
speci
tissu
type
complement
studi
perform
african
green
monkey
kidney
cell
includ
murin
fibroblast
cell
line
commonli
use
grow
reoviru
hela
cell
immort
human
cervic
epitheli
cell
line
hpde
cell
noncancer
human
pancreat
ductal
epitheli
cell
line
first
evalu
whether
sg
could
form
cell
type
treatment
mm
sa
min
induc
strong
sg
format
line
figur
next
assess
effect
pretreat
mm
sa
viral
permiss
cell
type
sinc
cell
line
differ
permiss
reoviru
perform
immunofluoresc
use
antibodi
determin
concentr
viru
requir
give
rise
cell
infect
chose
ensur
posit
neg
effect
sa
treatment
captur
consist
observ
cell
pretreat
sa
hpde
cell
result
higher
percentag
cell
exhibit
vf
untreat
cell
figur
hela
cell
howev
percent
infect
cell
compar
untreat
sa
pretreat
cell
figur
assess
static
permiss
hela
cell
viral
protein
express
compar
hela
cell
determin
express
level
reoviru
outer
capsid
protein
presenc
absenc
sa
pretreat
cell
pretreat
sa
min
prior
infect
moi
h
pi
cell
harvest
express
level
indic
protein
determin
immunoblot
consist
figur
h
pi
express
level
increas
cell
pretreat
sa
unchang
hela
cell
figur
c
differ
observ
hela
cell
result
failur
induc
sg
phosphoryl
inde
outcom
occur
hela
cell
respons
sa
treatment
figur
b
data
indic
activ
stress
respons
pathway
prior
infect
pretreat
sa
benefici
cell
type
prototyp
reoviru
strain
type
lang
type
abney
type
dear
differ
capac
induc
host
translat
shutoff
induc
phosphoryl
determin
benefit
pretreat
sa
reoviru
strain
specif
infect
cell
assess
percentag
infect
cell
h
pi
compar
untreat
cell
observ
follow
infect
strain
pretreat
sa
result
nearli
increas
percentag
cell
figur
sa
pretreat
cell
infect
yield
similar
result
howev
sa
pretreat
effect
strain
test
hela
cell
figur
f
data
suggest
reoviru
strain
benefit
pretreat
sa
prior
infect
cell
type
cellular
treatment
sa
produc
reactiv
oxygen
speci
ro
accumul
result
oxid
stress
activ
hri
kinas
hri
kinas
activ
erythrocyt
reduc
heme
avail
ubiquit
express
mani
tissu
activ
sa
phosphoryl
subsequ
induc
sg
format
hri
stress
kinas
requir
translat
inhibit
respons
arsenit
treatment
mous
embryon
fibroblast
hri
kinas
also
activ
cellular
stress
includ
osmot
stress
heat
shock
hs
assess
enhanc
reoviru
infect
follow
sa
treatment
specif
sa
assess
viral
protein
express
percentag
infect
cell
viral
yield
respons
hs
use
sg
induct
respons
hs
indirect
measur
hri
activ
unabl
detect
kinas
express
immunoblot
use
commerci
antibodi
figur
despit
mani
attempt
unsuccess
induc
sg
cell
hs
also
note
hs
fail
induc
phosphoryl
level
found
untreat
cell
figur
howev
readili
abl
induc
sg
cell
use
hs
hs
min
result
cell
contain
sg
increas
phosphoryl
compar
untreat
cell
figur
figur
assess
effect
hs
induct
isr
cell
similar
observ
cell
pretreat
sa
viral
protein
express
enhanc
h
pi
cell
expos
min
hs
prior
infect
figur
howev
hs
impact
percentag
infect
cell
viral
yield
cell
figur
find
suggest
cell
hs
enhanc
protein
express
affect
either
number
infect
cell
per
cell
yield
viru
although
hs
previous
shown
activ
hri
kinas
effect
cell
differ
sa
togeth
data
indic
sa
pretreat
perturb
cell
way
benefici
reoviru
compar
activ
isr
activ
isr
phosphoryl
result
suppress
gener
host
translat
differ
reoviru
strain
induc
translat
shutoff
vari
degre
viral
protein
synthesi
typic
peak
around
h
pi
found
viral
protein
express
increas
cell
pretreat
sa
prior
infect
increas
absent
cell
treat
immedi
prior
harvest
h
pi
figur
figur
furthermor
viral
protein
express
percentag
infect
cell
viral
yield
enhanc
activ
isr
use
hs
cell
figur
given
impact
protein
synthesi
multipl
cell
type
follow
treatment
differ
stress
hypothes
sa
treatment
might
enhanc
viral
translat
earli
time
post
infect
test
cell
either
left
untreat
unt
pretreat
mm
sa
min
prior
infect
presa
altern
follow
infect
mm
sa
ad
min
h
pi
assess
percentag
infect
cell
treatment
group
h
pi
consist
previou
data
pretreat
sa
prior
inocul
viru
result
increas
percentag
infect
cell
figur
b
addit
untreat
cell
infect
treat
sa
min
also
demonstr
increas
permiss
addit
sa
occur
within
first
h
infect
figur
b
howev
increas
permiss
greatest
sa
ad
prior
viru
infect
addit
sa
h
pi
later
effect
percentag
infect
cell
h
pi
figur
b
data
suggest
sa
benefici
ad
earli
viral
life
cycl
activ
hri
pkr
perk
kinas
respons
stress
result
phosphoryl
serin
posit
subsequ
induct
isr
respons
accumul
part
isr
includ
express
growth
arrest
dna
damag
protein
phosphataseinteract
protein
conjunct
protein
phosphatas
act
dephosphoryl
serin
time
cellular
stress
previous
shown
upregul
cell
follow
infect
reoviru
strain
induc
host
shutoff
find
thu
far
consist
previou
report
suggest
kinas
activ
benefici
reoviru
infect
therefor
hypothes
reoviru
may
capabl
viral
protein
synthesi
face
enhanc
phosphoryl
reason
inhibit
dephosphoryl
would
enhanc
phosphoryl
effect
viral
protein
synthesi
use
select
inhibitor
salubrin
prevent
activ
complex
without
affect
kinas
phosphoryl
confirm
salubrin
inhibit
dephosphoryl
expect
cell
either
incub
presenc
absenc
salubrin
h
treat
mm
sa
min
two
hour
follow
remov
sa
cell
lyse
immunoblot
perform
indic
protein
expect
treatment
sa
result
increas
phosphoryl
compar
untreat
cell
figur
express
level
enhanc
even
cell
incub
salubrin
prior
sa
treatment
figur
next
determin
impact
sustain
phosphoryl
reoviru
protein
express
immedi
follow
adsorpt
reoviru
cell
treat
increas
amount
salubrin
cell
harvest
h
pi
determin
viral
protein
express
figur
even
high
concentr
salubrin
impact
viral
protein
express
suggest
reoviru
toler
cellular
antivir
activ
phosphoryl
given
sa
known
induc
phosphoryl
also
test
impact
ad
salubrin
follow
reoviru
adsorpt
sa
pretreat
cell
figur
observ
neg
impact
viral
protein
express
cell
pretreat
sa
prior
infect
incub
presenc
salubrin
durat
infect
figur
consist
percentag
infect
cell
impact
addit
salubrin
untreat
cell
cell
pretreat
mm
sa
figur
togeth
data
suggest
sustain
result
salubrin
treatment
reoviru
infect
antivir
report
found
treatment
cell
sa
potent
induc
isr
phosphoryl
prior
inocul
reoviru
benefici
viru
strainindepend
celltypespecif
manner
sa
treatment
induc
format
reactiv
oxygen
speci
ro
within
cell
increas
intracellular
ro
turn
lead
activ
hri
phosphoryl
serin
residu
lead
gener
translat
repress
downstream
activ
isr
order
matur
becom
activ
hri
complex
addit
activ
hemedefici
hri
also
activ
hs
osmot
shock
er
stress
amino
acid
serum
starvat
contrast
enhanc
viral
replic
saw
follow
pretreat
sa
hs
pretreat
enhanc
viral
replic
hs
also
activ
hri
qualit
lower
level
sa
differ
pattern
autophosphoryl
hri
prestress
cell
sa
hs
benefit
viral
replic
unclear
possibl
kinet
magnitud
time
phosphoryl
follow
differ
stressor
vari
lead
differ
outcom
saw
altern
rule
possibl
sa
treatment
activ
respons
mediat
isr
benefit
viral
replic
addit
induc
phosphoryl
sa
induc
format
sg
consist
find
qin
et
al
found
reoviru
infect
induc
sg
format
earli
infect
number
sgcontain
cell
reduc
h
disappear
late
infect
data
cell
consist
report
smith
et
al
detect
sg
h
postinfect
cell
like
differ
strain
reoviru
induc
sg
vari
extent
influenc
cell
type
moi
data
use
strain
suggest
infect
strain
reoviru
result
low
level
sg
induct
absent
late
time
post
infect
time
sg
appear
peak
h
dissolut
begin
h
hand
support
idea
put
forth
qin
et
al
sg
induct
link
vf
format
onset
viral
translat
interfer
sg
stabil
smith
et
al
stain
reovirusinfect
cell
h
postinfect
sg
protein
tiar
costain
viral
protein
detect
vf
other
observ
sg
protein
local
outer
margin
vf
late
time
post
infect
fraction
reoviru
infect
cell
therefor
tiarposit
puncta
seen
h
post
infect
smith
may
fact
vf
costain
presenc
tiar
signific
sg
protein
reloc
vf
remain
determin
still
data
impli
reoviru
evolv
mechan
counter
cellular
antivir
activ
translat
suppress
sg
induct
examin
sg
sg
protein
detect
increas
tiar
express
immunoblot
h
pi
compar
h
pi
contrast
immunofluoresc
data
express
level
confound
observ
increas
tiar
express
untreat
cell
harvest
h
compar
h
previou
report
indic
time
stress
sg
protein
level
remain
constant
local
shift
tiar
rnabind
protein
found
primarili
nucleu
cycl
cell
involv
control
mitot
entri
capabl
shuttl
nucleu
cytoplasm
respons
stress
fasinduc
apoptosi
transcript
blockad
tiar
accumul
cytoplasm
movement
tiar
nucleu
also
observ
herp
simplex
viru
infect
cytoplasm
accumul
begin
earli
h
infect
studi
comparison
sg
protein
express
level
nucleu
cytoplasm
reveal
although
cytosol
express
level
increas
total
cellular
protein
level
constant
attribut
increas
tiar
express
late
time
post
infect
primarili
result
movement
tiar
cytoplasm
rule
possibl
increas
cytoplasm
express
result
viral
infect
similar
pattern
detect
uninfect
cell
suggest
like
result
transcript
blockad
associ
contact
inhibit
pretreat
cell
sa
led
enhanc
viral
protein
express
percent
infect
viral
titer
given
reoviru
compartment
translat
machineri
vf
compon
translat
machineri
also
sequest
within
sg
previous
specul
sg
may
serv
reservoir
translat
machineri
reoviru
vf
howev
comparison
reoviru
infect
follow
pretreat
either
sa
hs
suggest
benefit
independ
sg
format
treatment
result
robust
induct
sg
sa
pretreat
led
increas
viral
replic
late
time
pi
addit
sinc
unabl
achiev
robust
sg
format
follow
hs
cell
viral
replic
studi
perform
cell
therefor
rule
cellspecif
influenc
data
consist
find
smith
et
al
reoviru
benefit
activ
isr
studi
author
found
reoviru
replic
lower
titer
cell
lack
phosphorylat
sa
potent
activ
isr
samedi
activ
hri
kinas
lead
phosphoryl
downstream
upregul
transcript
mediat
isr
given
canon
capdepend
cellular
translat
reli
avail
activ
possibl
activ
isr
allow
reoviru
mrna
competit
advantag
limit
translat
machineri
effect
sa
greatest
ad
reoviru
adsorpt
still
benefici
treatment
occur
within
first
h
infect
translat
reoviru
mrna
rise
sharpli
h
pi
peak
h
pi
given
rise
level
viral
protein
synthesi
concomit
continu
host
protein
synthesi
possibl
sa
treatment
select
reduc
translat
machineri
avail
host
protein
synthesi
postul
heighten
phosphoryl
may
strongli
affect
mrna
contain
long
highli
structur
untransl
region
utr
reoviru
mrna
short
utr
possibl
provid
protect
viral
mrna
translat
find
reoviru
protein
express
infect
unaffect
treat
cell
salubrin
prevent
dephosphoryl
support
suggest
reoviru
refractori
salubrin
exposur
exclud
possibl
pretreat
cell
sa
effect
promot
viral
replic
independ
phosphoryl
reoviru
oncolyt
viru
preferenti
infect
cancer
cell
phenomenon
link
mutationallyact
ra
pathway
howev
report
conflict
regard
ra
depend
cancer
cell
elev
level
chaperon
facilit
high
level
protein
synthesi
typic
transform
cell
effici
mrna
translat
increas
presenc
supplement
recombin
rate
translat
elong
may
regul
chaperon
avail
treatment
sa
also
increas
chaperon
level
cell
furthermor
requir
hri
activ
blockad
disrupt
hri
activ
previous
report
specif
target
vf
site
reoviru
translat
although
protein
specif
recruit
remain
unclear
recruit
independ
chaperon
function
altern
sa
pretreat
might
alter
avail
protein
fold
chaperon
way
favor
earli
stage
reoviru
replic
previous
shown
promot
releas
fragment
reoviru
outer
capsid
protein
complet
disassembl
outer
capsid
deposit
transcript
activ
core
particl
cytosol
studi
fragment
releas
nearli
abolish
rabbit
reticulocyt
lysat
immunodeplet
could
restor
addit
purifi
suggest
role
viru
uncoat
infect
reoviru
result
increas
express
stress
respons
gene
includ
latter
complex
revers
phosphoryl
observ
type
dear
reoviru
protein
express
unaffect
presenc
salubrin
select
inhibitor
complex
respons
dephosphoryl
even
cell
pretreat
sa
elev
level
phosphoryl
observ
salubrin
antivir
reoviru
uniqu
rotaviru
fellow
member
reovirida
famili
well
virus
includ
hepat
c
viru
mous
hepat
coronaviru
demonstr
continu
viral
protein
synthesi
despit
heighten
phosphoryl
provid
addit
evid
reoviru
benefit
isr
import
note
reovirusinduc
express
stress
respons
gene
uniform
host
shutoff
strain
includ
type
abney
induc
increas
express
gene
compar
consid
host
shutoff
strain
reoviru
strain
test
includ
benefit
sa
pretreat
host
shutoff
strain
may
respond
differ
salubrin
treatment
addit
strainspecif
differ
abil
induc
host
shutoff
cell
differ
also
record
instanc
reovirusinduc
host
shutoff
observ
hela
cell
cell
may
link
observ
infect
hela
cell
unaffect
sa
pretreat
wherea
sa
pretreat
benefici
cell
type
includ
cell
hpde
cell
overal
studi
find
sainduc
activ
isr
prior
reoviru
inocul
result
enhanc
viral
protein
express
percent
infect
viral
yield
furthermor
activ
isr
insuffici
replic
enhanc
hs
sa
activ
isr
sa
treatment
associ
increas
viral
infect
higher
yield
final
sainduc
enhanc
observ
across
reoviru
strain
observ
cell
type
suggest
role
cell
typespecif
influenc
understand
interplay
reoviru
isr
modul
enhanc
viru
replic
could
reveal
novel
target
strengthen
oncolyt
potenti
reoviru
